TRIPS

Cyber Economics Espionage: Is TRIPS the solution?

Economic espionage has been a hot topic of sorts since the September 2015 agreement was made between USA and China, that called for both the countries to not knowingly conduct or support cyber enabled trade secret theft from companies in each others’ land with the intent of providing competitive advantage to its companies of [...]

By |2017-09-08T10:57:53+05:30March 27th, 2017|IP Basics|0 Comments

Cyber Economics Espionage: Is TRIPS the solution?

Economic espionage has been a hot topic of sorts since the September 2015 agreement was made between USA and China, that called for both the countries to not knowingly conduct or support cyber enabled trade secret theft from companies in each others’ land with the intent of providing competitive advantage to its companies of [...]

By |2017-09-08T11:05:25+05:30March 27th, 2017|IP Basics|0 Comments

UN Human Rights Council adopts landmark resolution on access to medicines

The UN Human Rights Council (UNHRC) on Friday adopted a landmark resolution on access to medicines- in order to examine the relation between intellectual property rights, trade agreements and access issues- sponsored by a group of developing countries, including India. The resolution - Access to medicines in the context of the right of everyone to the enjoyment [...]

By |2017-08-31T14:56:52+05:30March 6th, 2017|IP Basics, International|0 Comments

Geographical Indication : ” Tirupati Laddu ” valid

Geographical Indication is used to denote the name or sign, of the products which are from a particular geographical area or somewhat related to the origin like town, region or nation. Thus Geographical Indication gives the rights to its holder, and acts as the certification mark and also shows that the specified product consists [...]

By |2017-09-07T13:21:54+05:30September 13th, 2012|Patent|0 Comments

Battle between Indian Companies and Global Giants

The ultra powerful pharmaceutical multi nationals are facing a setback due to India’s weak patent regime for medicines. India has been favoring the low cost Indian generic companies. Also, recently the Indian patent office granted compulsory license allowing Natco Pharma Ltd to make and sell a copy of German drug maker Bayer AG’s patented [...]

By |2017-09-07T13:12:40+05:30May 9th, 2012|Patent|0 Comments
Go to Top